| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Endocrinology and Metabolism |
1 Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN.
aAddress correspondence to this author at: Hilton 730, Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, 200 First St. SW, Rochester, MN 55905. Fax 507-284-9758; e-mail singh.ravinder{at}mayo.edu.
Background: Estradiol (E2) and estrone (E1) measurements form an integral part of the assessment of female reproductive function and have expanding roles in other fields. However, many E1 and E2 immunoassays have limited functional sensitivity, suffer from cross-reactivity, and display poor intermethod agreement. To overcome these problems, we developed a sensitive liquid chromatography–tandem mass spectrometry (LC-MS/MS) assay for the simultaneous measurement of E1 and E2.
Methods: After dansyl chloride derivatization, samples were separated by fast gradient chromatography and injected into a tandem mass spectrometer after formation of positive ions with atmospheric pressure chemical ionization. The limits of detection and quantification, recovery, linearity, precision, and reference intervals were determined, and performance was compared with several immunoassays.
Results: Total run time per sample was 5 min. The multiple-reaction monitoring ion pairs were m/z 506/171 for 3-dansyl-estradiol and m/z 504/171 for 3-dansyl-estrone. The limits of detection for E1 and E2 were 12.9 pmol/L (3.5 ng/L) and 10.3 pmol/L (2.8 ng/L), respectively. Interassay imprecision (CV) was 4–20% (n = 20). The limits of quantification (functional sensitivities) for E1 and E2 were 44.1 pmol/L (11.9 ng/L) and 23.2 pmol/L (6.3 ng/L), respectively. The assay was linear to >2200 pmol/L (
600 ng/L) for each analyte. Recoveries were 93–108% for E1 and 100–110% for E2. No cross-reactivity was observed. Method comparison with several immunoassays revealed that the latter were inaccurate and prone to interferences at low E1 and E2 concentrations.
Conclusions: LC-MS/MS allows rapid, simultaneous, sensitive, and accurate quantification of E1 and E2 in human serum.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  P. H. A. Ronkainen, V. Kovanen, M. Alen, E. Pollanen, E.-M. Palonen, C. Ankarberg-Lindgren, E. Hamalainen, U. Turpeinen, U. M. Kujala, J. Puolakka, et al. Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs J Appl Physiol, July 1, 2009; 107(1): 25 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Soldin and O. P. Soldin Steroid Hormone Analysis by Tandem Mass Spectrometry Clin. Chem., June 1, 2009; 55(6): 1061 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ankarberg-Lindgren, E. Norjavaara, M. M. Kushnir, W. L. Roberts, A. L. Rockwood, J. Bergquist, A. M. Bunker, and A. W. Meikle Are Estradiol Results Determined by the Tandem Mass Spectrometry Assay Clinically Useful for Children? Am J Clin Pathol, May 1, 2009; 131(5): 746 - 750. [Full Text] [PDF]
|
|
|
|
|
|
T. Finni, V. Kovanen, P. H. A. Ronkainen, E. Pollanen, G. R. Bashford, J. Kaprio, M. Alen, U. M. Kujala, and S. Sipila Combination of hormone replacement therapy and high physical activity is associated with differences in Achilles tendon size in monozygotic female twin pairs J Appl Physiol, April 1, 2009; 106(4): 1332 - 1337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H Abbott, D. K Barnett, J. E Levine, V. Padmanabhan, D. A Dumesic, S. Jacoris, and A. F Tarantal Endocrine Antecedents of Polycystic Ovary Syndrome in Fetal and Infant Prenatally Androgenized Female Rhesus Monkeys Biol Reprod, July 1, 2008; 79(1): 154 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mauras, L. Gonzalez de Pijem, H. Y. Hsiang, P. Desrosiers, R. Rapaport, I. D. Schwartz, K. O. Klein, R. J. Singh, A. Miyamoto, and K. Bishop Anastrozole Increases Predicted Adult Height of Short Adolescent Males Treated with Growth Hormone: A Randomized, Placebo-Controlled, Multicenter Trial for One to Three Years J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 823 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ankarberg-Lindgren and E. Norjavaara A purification step prior to commercial sensitive immunoassay is necessary to achieve clinical usefulness when quantifying serum 17 -estradiol in prepubertal children Eur. J. Endocrinol., January 1, 2008; 158(1): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tivesten, D. Mellstrom, H. Jutberger, B. Fagerberg, B. Lernfelt, E. Orwoll, M. K. Karlsson, O. Ljunggren, and C. Ohlsson Low Serum Testosterone and High Serum Estradiol Associate With Lower Extremity Peripheral Arterial Disease in Elderly Men: The MrOS Study in Sweden J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1070 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Z. Stanczyk, J. S. Lee, and R. J. Santen Standardization of Steroid Hormone Assays: Why, How, and When? Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1713 - 1719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wang, P. Christenson, and R. Swerdloff Clinical Relevance of Racial and Ethnic Differences in Sex Steroids J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2433 - 2435. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Usa, R. J. Singh, B. C. Netzel, Y. Liu, H. Raff, and M. Liang Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats Am J Physiol Renal Physiol, July 1, 2007; 293(1): F186 - F192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tivesten, J. Hulthe, K. Wallenfeldt, J. Wikstrand, C. Ohlsson, and B. Fagerberg Circulating Estradiol Is an Independent Predictor of Progression of Carotid Artery Intima-Media Thickness in Middle-Aged Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4433 - 4437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Lee, B. Ettinger, F. Z. Stanczyk, E. Vittinghoff, V. Hanes, J. A. Cauley, W. Chandler, J. Settlage, M. S. Beattie, E. Folkerd, et al. Comparison of Methods to Measure Low Serum Estradiol Levels in Postmenopausal Women J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3791 - 3797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Aksglaede, A. Juul, H. Leffers, N. E. Skakkebaek, and A.-M. Andersson The sensitivity of the child to sex steroids: possible impact of exogenous estrogens Hum. Reprod. Update, July 1, 2006; 12(4): 341 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Kushnir, A. L. Rockwood, W. L. Roberts, E. G. Pattison, A. M. Bunker, R. L. Fitzgerald, and A. W. Meikle Performance Characteristics of a Novel Tandem Mass Spectrometry Assay For Serum Testosterone Clin. Chem., January 1, 2006; 52(1): 120 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sikaris, R. I. McLachlan, R. Kazlauskas, D. de Kretser, C. A. Holden, and D. J. Handelsman Reproductive Hormone Reference Intervals for Healthy Fertile Young Men: Evaluation of Automated Platform Assays J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5928 - 5936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Toran-Allerand, A. A. Tinnikov, R. J. Singh, and I. S. Nethrapalli 17{alpha}-Estradiol: A Brain-Active Estrogen? Endocrinology, September 1, 2005; 146(9): 3843 - 3850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Taylor, S. K. Grebe, and R. J. Singh Quantitative, Highly Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Detection of Synthetic Corticosteroids Clin. Chem., December 1, 2004; 50(12): 2345 - 2352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kinter Toward Broader Inclusion of Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory Clin. Chem., September 1, 2004; 50(9): 1500 - 1502. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
